| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021391886 |
| P356 | DOI | 10.1007/S12026-015-8783-5 |
| P698 | PubMed publication ID | 26754764 |
| P5875 | ResearchGate publication ID | 290221991 |
| P2093 | author name string | Horea Rus | |
| Dallas Boodhoo | |||
| Sonia I Vlaicu | |||
| Alexandru Tatomir | |||
| Petru A Mircea | |||
| Stefan Vesa | |||
| P2860 | cites work | Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk | Q58037914 |
| Detection of refolding conformers of complement protein C9 during insertion into membranes | Q59046450 | ||
| The Complement Abnormalities of Lipodystrophy | Q67433383 | ||
| Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque | Q68888362 | ||
| Ultrastructural localization of the membrane attack complex of complement in human renal tissues | Q68941322 | ||
| Activation of the human terminal complement pathway in atherosclerosis | Q69007426 | ||
| Cells carrying C5b-9 complement complexes in human atherosclerotic wall | Q69599663 | ||
| Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space | Q69856269 | ||
| Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque | Q69924809 | ||
| Increased level of the complement C3 protein in endogenous hypertriglyceridemia | Q70432122 | ||
| Differentiation-induced production of ASP in human adipocytes | Q70953487 | ||
| Partial lipodystrophy and familial C3 deficiency | Q71142680 | ||
| ASP stimulates glucose transport in cultured human adipocytes | Q73294623 | ||
| Local activation of the complement system in endoneurial microvessels of diabetic neuropathy | Q73392993 | ||
| Acylation stimulating protein stimulates insulin secretion | Q73807086 | ||
| C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis | Q75317796 | ||
| Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase | Q77910759 | ||
| Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells | Q78007332 | ||
| Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice | Q79291846 | ||
| Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda | Q79452847 | ||
| Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors | Q79693121 | ||
| Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study | Q80229831 | ||
| Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study | Q81690810 | ||
| Complement activation in diabetic ketoacidosis and its treatment | Q81799236 | ||
| Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control | Q86383152 | ||
| Serum mannose-binding lectin is a strong biomarker of diabetic retinopathy in chinese patients with diabetes | Q86901917 | ||
| Determination of reference intervals for serum complement C3 and C4 levels in Chinese Han ethnic males | Q87902579 | ||
| RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase | Q24291853 | ||
| Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue | Q24292702 | ||
| Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells | Q24319998 | ||
| Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL | Q24669594 | ||
| Membrane attack by complement: the assembly and biology of terminal complement complexes | Q26997385 | ||
| Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes | Q28577330 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| An integrative genomics approach to infer causal associations between gene expression and disease | Q29616385 | ||
| Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. | Q30384917 | ||
| Complement factor H is expressed in adipose tissue in association with insulin resistance | Q33556525 | ||
| Acylation stimulating protein (ASP), an adipocyte autocrine: new directions | Q33650742 | ||
| Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis | Q33661588 | ||
| Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humans | Q33682481 | ||
| C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. | Q33745559 | ||
| Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice | Q33873819 | ||
| Adipsin is an adipokine that improves β cell function in diabetes | Q34025740 | ||
| Complement and its role in innate and adaptive immune responses | Q34088142 | ||
| C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling | Q34309482 | ||
| Response gene to complement 32 (RGC-32) in endothelial cells is induced by glucose and helpful to maintain glucose homeostasis. | Q34414925 | ||
| Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms | Q34442404 | ||
| Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers | Q34557152 | ||
| Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance | Q34605296 | ||
| RGC32 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice | Q34944257 | ||
| Beyond lysis: how complement influences cell fate. | Q35064278 | ||
| Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study | Q35118002 | ||
| Adaptive expression of microRNA-125a in adipose tissue in response to obesity in mice and men. | Q35133482 | ||
| Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration | Q35135052 | ||
| Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women | Q35151778 | ||
| Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes | Q42834039 | ||
| Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy | Q43940024 | ||
| Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study | Q44015071 | ||
| High expression of complement components in omental adipose tissue in obese men. | Q44477341 | ||
| Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance | Q44620944 | ||
| Obesity-inducing diet promotes acylation stimulating protein resistance. | Q44845545 | ||
| Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes | Q45077962 | ||
| Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes | Q45739398 | ||
| Complement-mediated chronic inflammation is associated with diabetic microvascular complication | Q46096929 | ||
| Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents | Q46355388 | ||
| Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children | Q46457269 | ||
| Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein | Q47245431 | ||
| Complement activation in diabetic ketoacidosis brains | Q48640667 | ||
| The complement inhibitor CD59 regulates insulin secretion by modulating exocytotic events. | Q50802836 | ||
| C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors. | Q51144592 | ||
| Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4. | Q51313938 | ||
| Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM Study. | Q51323653 | ||
| Possible direct influence of complement 3 in decreasing insulin sensitvity in a cohort of overweight and obese subjects. | Q51328491 | ||
| Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. | Q51559463 | ||
| Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians. | Q51560677 | ||
| Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. | Q51561024 | ||
| Plasma acylation-stimulating protein in coronary artery disease. | Q51574574 | ||
| The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane | Q52736479 | ||
| C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. | Q53624797 | ||
| Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries. | Q53811496 | ||
| The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization. | Q54458101 | ||
| Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. | Q55051842 | ||
| Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice | Q55162949 | ||
| Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population | Q56994562 | ||
| Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: The CODAM study | Q57415486 | ||
| The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism | Q35159111 | ||
| Elevated serum levels of mannose-binding lectin and diabetic nephropathy in type 2 diabetes | Q35213862 | ||
| Role of complement and complement regulatory proteins in the complications of diabetes | Q35657115 | ||
| The role of complement activation in atherosclerosis | Q35838666 | ||
| Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes | Q35841122 | ||
| Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. | Q35841134 | ||
| Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement | Q36278524 | ||
| Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells | Q36362882 | ||
| Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance | Q36442478 | ||
| Clinical analysis of selected complement-derived molecules in human adipose tissue | Q36604268 | ||
| Molecular basis for a link between complement and the vascular complications of diabetes | Q36977373 | ||
| Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice. | Q37104156 | ||
| Role of response gene to complement 32 in diseases | Q37121718 | ||
| The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance | Q37280702 | ||
| Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis | Q37311913 | ||
| Adipokines and the immune system: an adipocentric view. | Q37331640 | ||
| RGC-32 is a novel regulator of the T-lymphocyte cell cycle | Q37334611 | ||
| Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men. | Q37515367 | ||
| Innate immunity and adipose tissue biology | Q37740579 | ||
| Acylation stimulating protein: a female lipogenic factor? | Q37846807 | ||
| Complement C3 and cleavage products in cardiometabolic risk | Q37854933 | ||
| Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer | Q38068141 | ||
| The role of the complement system in metabolic organs and metabolic diseases | Q38107674 | ||
| Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus | Q38118441 | ||
| Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis | Q38188132 | ||
| Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes | Q38318585 | ||
| The role of complement factor C3 in lipid metabolism | Q38369254 | ||
| The role of complement activation in atherogenesis: the first 40 years | Q38532361 | ||
| Beta cell dysfunction and insulin resistance | Q39325879 | ||
| A new effector of lipid metabolism: complement factor properdin | Q39386373 | ||
| Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells | Q40304477 | ||
| Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study | Q40327679 | ||
| Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. | Q40450370 | ||
| Association of serum C3 levels with the risk of myocardial infarction. | Q40989911 | ||
| Complement-mediated adipocyte lysis by nephritic factor sera | Q41980848 | ||
| Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin | Q42473514 | ||
| Complement C3: an emerging risk factor in cardiometabolic disease | Q42594073 | ||
| The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation | Q42796229 | ||
| Adipsin and an endogenous pathway of complement from adipose cells. | Q42818598 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 653-664 | |
| P577 | publication date | 2016-01-11 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | The role of complement system in adipose tissue-related inflammation | |
| P478 | volume | 64 |
| Q50957783 | Adipocyte-Macrophage Cross-Talk in Obesity. |
| Q92423266 | Breed, Diet, and Interaction Effects on Adipose Tissue Transcriptome in Iberian and Duroc Pigs Fed Different Energy Sources |
| Q57300387 | Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic Rats |
| Q30274952 | Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds |
| Q90173708 | Complement Activation in 22q11.2 Deletion Syndrome |
| Q36140527 | Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis. |
| Q38747312 | Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications |
| Q90289775 | Complement and human T cell metabolism: Location, location, location |
| Q55354179 | Diet-Induced Obesity Affects Muscle Regeneration After Murine Blunt Muscle Trauma-A Broad Spectrum Analysis. |
| Q51418313 | Differentiating lipedema and Dercum's disease. |
| Q92072061 | Free Fatty Acids in Bone Pathophysiology of Rheumatic Diseases |
| Q37747837 | Human serum RNase-L level is inversely associated with metabolic syndrome and age. |
| Q92122504 | Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future |
| Q51631005 | Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome. |
| Q51281718 | Lectin complement pathway proteins in healthy individuals. |
| Q51732921 | Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation. |
| Q54650430 | Obesity-induced metabolic disturbance drives oxidative stress and complement activation in the retinal environment. |
| Q91351180 | Omentin-regulated proteins combine a pro-inflammatory phenotype with an anti-inflammatory counterregulation in human adipocytes: A proteomics analysis |
| Q49709266 | Osteoarthritis and the Complement Cascade |
| Q39400021 | RGC-32 is expressed in the human atherosclerotic arterial wall: Role in C5b-9-induced cell proliferation and migration |
| Q92282860 | Resistin and Cardiac Arrest-A Prospective Study |
| Q91121470 | Role of Complement and Complement-Related Adipokines in Regulation of Energy Metabolism and Fat Storage |
Search more.